is in focus after its subsidiary, PathLabs Unifiers, acquired the remaining 30% equity stake in Centrapath Labs. Acquisitions can help diagnostic companies expand their geographic presence, strengthen laboratory networks and improve service coverage. Investors should examine the purchase consideration, expected synergies, integration costs, acquired business performance and whether the transaction improves earnings per share over time. The healthcare diagnostics sector also depends on test volumes, pricing, customer retention and operational efficiency.
Learning point: An acquisition creates value only when its strategic and financial benefits justify the purchase cost and integration risks.